Recent Achievements
Completion of a successful multicenter Phase II/III randomized, placebo-controlled, 644-patient clinical trial of Zindol®, an enhanced ginger product in gel capsules, as an adjunctive therapy for chemotherapy induced nausea and vomiting (CINV).
- Nanoencapsulation of siRNA using Aphios' SuperFluids™ CFN technology to improve its delivery and therapeutic efficacy in collaboration with a top five multinational pharmaceutical company.
- Frost & Sullivan 2009 North American Excellence in Healthcare Technology Innovation of the Year Best Practices Award in the field of Enhanced Nanodrug Therapeutic Systems for SuperFluids™ nanodrug solubility, encapsulation and delivery platforms.
Read 498 times

